Journal of Clinical Medicine (Jul 2020)

Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients

  • Teresa Strisciuglio,
  • Raffaele Izzo,
  • Emanuele Barbato,
  • Giuseppe Di Gioia,
  • Iginio Colaiori,
  • Antonella Fiordelisi,
  • Carmine Morisco,
  • Jozef Bartunek,
  • Danilo Franco,
  • Giuseppe Ammirati,
  • Valerio Pergola,
  • Livio Imparato,
  • Bruno Trimarco,
  • Giovanni Esposito,
  • Antonio Rapacciuolo

DOI
https://doi.org/10.3390/jcm9072144
Journal volume & issue
Vol. 9, no. 7
p. 2144

Abstract

Read online

Background: Insulin resistance (IR) in patients with type 2 diabetes mellitus (T2DM) represents a predictor of coronary artery disease (CAD). However, how IR is able to impact the severity of coronary atherosclerosis in non-diabetic patients is unknown. Objectives. We investigated the relation between the IR and the extent and severity of coronary atherosclerosis in non-diabetic patients referred to coronary angiography (CA) Methods: Consecutive patients undergoing to CA for acute coronary syndromes or stable angina were analyzed. The IR was assessed by mean of the homeostasis model assessment of insulin resistance (HOMA-IR) whereas the SYNTAX score (SS) was used as index of the severity of coronary atherosclerosis Results: Overall, 126 patients were included, with a median SS of 12 (IQR 5.25–20.5). Patients were divided in four groups according to the distribution in quartiles of SS (SS1-2-3-4). A significant correlation between HOMA-IR and SS was observed, especially in women. A progressive increase of HOMA-IR was observed in parallel with the increasing severity (from SS1 to SS4) and extension (1-2-3-vessel disease) of coronary atherosclerosis. Multivariable analysis showed that the HOMA-IR was the strongest independent predictor of severe (SS4) and extensive (three-vessel disease) coronary atherosclerosis. Conclusion: Insulin resistance goes hand in hand with the extension and severity of coronary atherosclerosis in non-diabetic patients. The HOMA index is an independent predictor of three-vessel disease at CA. The HOMA index could be useful for risk stratification of CAD even in absence of T2DM.

Keywords